Breast Cancer
Finding a New Beat: Drumming as Therapy for Breast Cancer
BY MELISSA MILLS, BSN, RN, CCM, MHA
FDA Grants Priority Review to Talazoparib for Use in BRCA+ Breast Cancer
BY JASON M. BRODERICK
ASCO 2018 Highlights: Is Your Immune System Born or Made?
BY MAGGIE A. SMITH, DNP, MSN/ED, RN, OCN
Endocrine Therapy Alone Shows Benefit for Some with Early Breast Cancer
BY LISA SCHULMEISTER, MN, RN, FAAN
AKT Inhibitor May Overcome Chemotherapy Resistance in TNBC
BY ARIELA KATZ
Oncology Nurses Key in Addressing Patient Adherence to Ribociclib Treatment
BY JESSICA SKARZYNSKI
Changes in Olaparib Indications Demonstrate Need for Best Practices for Nurses
BY JESSICA SKARZYNSKI
Nurses Should Explore the Value of Cardiac Monitoring Among Younger Breast Cancer Survivors
BY BETH FAND INCOLLINGO
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.